author-photo

S. M. Ansell

University of Texas MD Anderson Cancer Center

3

Papers

355

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (321)
Results from a pivotal phase II study of brentuximab vedotin (SGN-35) in patients with relapsed or refractory Hodgkin lymphoma (HL).

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (34)
Proteomic analysis of patients with mantle cell lymphoma identifies Hsp90, and other proteins as potential target(s) for drug therapy

2004 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)